Dawn of a New Era: Evolving Needs, Solutions and Technology in U.S. HEOR

The U.S. health economics and outcomes research (HEOR) field has seen many changes over the last decade, including significant growth driven by payers, regulators and clinicians who are increasingly looking to Real-World Evidence (RWE) as a valuable source for patient-level data. To understand the implications of this growth, the Trinity Life Sciences Evidence Strategy team sought to gain a multi-disciplinary view on where and how HEOR experts see the field evolving and to better understand how HEOR capabilities can be best leveraged across the life sciences industry to improve patient outcomes.

Our goal was to gather HEOR thought leaders across the industry including representatives from pharmaceutical, medical devices/diagnostics and academia to weigh in on these topics. The objective was to gather perspectives on an extensive range of topics including the future of HEOR as a field, its ability to drive decision-making, its central role across the entire lifecycle and evidence generation overall—both in the U.S. and abroad. Our discussions centered around how HEOR and evidence generation will play a role in the evolution of the life sciences industry, from pharmaceuticals and biotechnology to devices and diagnostics. Most importantly, we discussed outcomes overall–including the individual and societal levels, as well as public health. Across the interviews, the discussion focused on the growing importance of Real-World Data (RWD) and specifically on data on social determinants of health (SDOH) and patient-reported outcomes (PROs).

In the paper that follows, we share with you our findings, the methods we used and most importantly, the great perspectives we heard. In addition, we offer (often in the words of the respondents themselves) insights into the current and future field of HEOR and evidence generation overall, articulating why this is an important function for any aspiring life sciences company. Through this initiative, we begin to illuminate how the healthcare industry can best utilize the HEOR specialty to unlock the potential value in a therapy or technology via rigorous analyses and well-articulated value stories.

Complete the form below to access the full whitepaper

We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.